{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:22:43Z","timestamp":1787570563405,"version":"build-2736575974"},"reference-count":64,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"},{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"},{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR070179"],"award-info":[{"award-number":["R01AR070179"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["R01DE031273"],"award-info":[{"award-number":["R01DE031273"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM142304"],"award-info":[{"award-number":["GM142304"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL094463"],"award-info":[{"award-number":["R01HL094463"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["ZIC ES102645"],"award-info":[{"award-number":["ZIC ES102645"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elifesciences.org"],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>\n                    TRAIL (TNF-related apoptosis-inducing ligand) is a potent inducer of tumor cell apoptosis through TRAIL receptors. While it has been previously pursued as a potential anti-tumor therapy, the enthusiasm subsided due to unsuccessful clinical trials and the fact that many tumors are resistant to TRAIL. In this report, we identified heparan sulfate (HS) as an important regulator of TRAIL-induced apoptosis. TRAIL binds HS with high affinity (\n                    <jats:italic>K<\/jats:italic>\n                    <jats:sub>D<\/jats:sub>\n                    = 73 nM) and HS induces TRAIL to form higher-order oligomers. The HS-binding site of TRAIL is located at the N-terminus of soluble TRAIL, which includes three basic residues. Binding to cell surface HS plays an essential role in promoting the apoptotic activity of TRAIL in both breast cancer and myeloma cells, and this promoting effect can be blocked by heparin, which is commonly administered to cancer patients. We also quantified HS content in several lines of myeloma cells and found that the cell line showing the most resistance to TRAIL has the least expression of HS, which suggests that HS expression in tumor cells could play a role in regulating sensitivity towards TRAIL. We also discovered that death receptor 5 (DR5), TRAIL, and HS can form a ternary complex and that cell surface HS plays an active role in promoting TRAIL-induced cellular internalization of DR5. Combined, our study suggests that TRAIL-HS interactions could play multiple roles in regulating the apoptotic potency of TRAIL and might be an important point of consideration when designing future TRAIL-based anti-tumor therapy.\n                  <\/jats:p>","DOI":"10.7554\/elife.90192","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T09:39:39Z","timestamp":1695893979000},"update-policy":"https:\/\/doi.org\/10.7554\/elife.90192","source":"Crossref","is-referenced-by-count":1,"title":["Heparan sulfate promotes TRAIL-induced tumor cell apoptosis"],"prefix":"10.7554","volume":"12","author":[{"given":"Yin","family":"Luo","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01q1z8k08","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Oral Biology, School of Dental Medicine, University at Buffalo, The State University of New York","place":["Buffalo, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"data-curation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"}]},{"given":"Huanmeng","family":"Hao","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01q1z8k08","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Oral Biology, School of Dental Medicine, University at Buffalo, The State University of New York","place":["Buffalo, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"data-curation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"}]},{"given":"Zhangjie","family":"Wang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0130frc33","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina","place":["Chapel Hill, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"data-curation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"}]},{"given":"Chih Yean","family":"Ong","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01q1z8k08","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Oral Biology, School of Dental Medicine, University at Buffalo, The State University of New York","place":["Buffalo, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"data-curation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5144-2111","authenticated-orcid":true,"given":"Robert","family":"Dutcher","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00j4k1h63","id-type":"ROR","asserted-by":"publisher"}],"name":"Macromolecular Structure Group, Epigenetics and Stem Cell Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health","place":["Research Triangle Park, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"data-curation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"}]},{"given":"Yongmei","family":"Xu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0130frc33","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina","place":["Chapel Hill, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"methodology","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"}]},{"given":"Jian","family":"Liu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0130frc33","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina","place":["Chapel Hill, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Lars C","family":"Pedersen","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00j4k1h63","id-type":"ROR","asserted-by":"publisher"}],"name":"Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health","place":["Research Triangle Park, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"conceptualization","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9380-2712","authenticated-orcid":true,"given":"Ding","family":"Xu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01q1z8k08","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Oral Biology, School of Dental Medicine, University at Buffalo, The State University of New York","place":["Buffalo, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"},{"role":"conceptualization","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]}],"member":"4374","published-online":{"date-parts":[[2024,1,24]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","type":"journal-article","article-title":"PHENIX: a comprehensive python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallographica. Section D, Biological Crystallography"},{"key":"bib2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aav8075","type":"journal-article","article-title":"Design of anti-inflammatory heparan sulfate to protect against acetaminophen-induced acute liver failure","volume":"12","author":"Arnold","year":"2020","journal-title":"Science Translational Medicine"},{"key":"bib3","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.733688","type":"journal-article","article-title":"Death receptors DR4 and DR5 undergo spontaneous and ligand-mediated endocytosis and recycling regardless of the sensitivity of cancer cells to TRAIL","volume":"9","author":"Artykov","year":"2021","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1172\/JCI6926","type":"journal-article","article-title":"Safety and antitumor activity of recombinant soluble Apo2 ligand","volume":"104","author":"Ashkenazi","year":"1999","journal-title":"The Journal of Clinical Investigation"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/nature05817","type":"journal-article","article-title":"Heparan sulphate proteoglycans fine-tune mammalian physiology","volume":"446","author":"Bishop","year":"2007","journal-title":"Nature"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/s1074-7613(00)80100-4","type":"journal-article","article-title":"2.8 A resolution crystal structure of human TRAIL, A cytokine with selective antitumor activity","volume":"11","author":"Cha","year":"1999","journal-title":"Immunity"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"31171","DOI":"10.1074\/jbc.M004414200","type":"journal-article","article-title":"Crystal structure of TRAIL-DR5 complex identifies a critical role of the unique frame insertion in conferring recognition specificity","volume":"275","author":"Cha","year":"2000","journal-title":"The Journal of Biological Chemistry"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","type":"journal-article","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallographica. Section D, Biological Crystallography"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1158\/1535-7163.MCT-11-0620","type":"journal-article","article-title":"A 71-gene signature of TRAIL sensitivity in cancer cells","volume":"11","author":"Chen","year":"2012","journal-title":"Molecular Cancer Therapeutics"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"833","DOI":"10.18632\/oncotarget.542","type":"journal-article","article-title":"Mislocalization of death receptors correlates with cellular resistance to their cognate ligands in human breast cancer cells","volume":"3","author":"Chen","year":"2012","journal-title":"Oncotarget"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.matbio.2013.10.004","type":"journal-article","article-title":"Heparan sulfate proteoglycan as a cell-surface endocytosis receptor","volume":"35","author":"Christianson","year":"2014","journal-title":"Matrix Biology"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1107\/S0021889812048698","type":"journal-article","article-title":"Implementation and performance of SIBYLS: a dual endstation small-angle X-ray scattering and macromolecular crystallography beamline at the Advanced Light Source","volume":"46","author":"Classen","year":"2013","journal-title":"Journal of Applied Crystallography"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrd3930","type":"journal-article","article-title":"Clinical targeting of the TNF and TNFR superfamilies","volume":"12","author":"Croft","year":"2013","journal-title":"Nature Reviews. Drug Discovery"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/s1074-7613(00)80399-4","type":"journal-article","article-title":"The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain","volume":"7","author":"Degli-Esposti","year":"1997","journal-title":"Immunity"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"14363","DOI":"10.1074\/jbc.273.23.14363","type":"journal-article","article-title":"Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL","volume":"273","author":"Emery","year":"1998","journal-title":"The Journal of Biological Chemistry"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","type":"journal-article","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallographica. Section D, Biological Crystallography"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","type":"journal-article","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallographica. Section D, Biological Crystallography"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1146\/annurev.biochem.71.110601.135458","type":"journal-article","article-title":"Order out of chaos: assembly of ligand binding sites in heparan sulfate","volume":"71","author":"Esko","year":"2002","journal-title":"Annual Review of Biochemistry"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1002\/cam4.137","type":"journal-article","article-title":"Phase 2, multicenter, open-label study of tigatuzumab (CS-1008), a humanized monoclonal antibody targeting death receptor 5, in combination with gemcitabine in chemotherapy-naive patients with unresectable or metastatic pancreatic cancer","volume":"2","author":"Forero-Torres","year":"2013","journal-title":"Cancer Medicine"},{"key":"bib20","doi-asserted-by":"publisher","DOI":"10.1038\/srep26245","type":"journal-article","article-title":"Epitope mapping by a Wnt-blocking antibody: evidence of the Wnt binding domain in heparan sulfate","volume":"6","author":"Gao","year":"2016","journal-title":"Scientific Reports"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1016\/j.yexcr.2007.03.018","type":"journal-article","article-title":"Membrane expression of DR4, DR5 and caspase-8 levels, but not Mcl-1, determine sensitivity of human myeloma cells to Apo2L\/TRAIL","volume":"313","author":"G\u00f3mez-Benito","year":"2007","journal-title":"Experimental Cell Research"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/sj.cdd.4401647","type":"journal-article","article-title":"Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation","volume":"12","author":"Hendriks","year":"2005","journal-title":"Cell Death and Differentiation"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1200\/JCO.2009.25.1991","type":"journal-article","article-title":"Phase I dose-escalation study of recombinant human Apo2L\/TRAIL, a dual proapoptotic receptor agonist, in patients with advanced cancer","volume":"28","author":"Herbst","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1107\/S1600576717011438","type":"journal-article","article-title":"BioXTAS RAW: improvements to a free open-source program for small-angle X-ray scattering data reduction and analysis","volume":"50","author":"Hopkins","year":"2017","journal-title":"Journal of Applied Crystallography"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1172\/JCI33760","type":"journal-article","article-title":"APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa","volume":"118","author":"Huard","year":"2008","journal-title":"The Journal of Clinical Investigation"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/s1097-2765(00)80207-5","type":"journal-article","article-title":"Triggering cell death: the crystal structure of Apo2L\/TRAIL in a complex with death receptor 5","volume":"4","author":"Hymowitz","year":"1999","journal-title":"Molecular Cell"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1021\/bi992242l","type":"journal-article","article-title":"A unique zinc-binding site revealed by A high-resolution X-ray structure of homotrimeric Apo2L\/TRAIL","volume":"39","author":"Hymowitz","year":"2000","journal-title":"Biochemistry"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1084\/jem.20042309","type":"journal-article","article-title":"Identification of proteoglycans as the APRIL-specific binding partners","volume":"201","author":"Ingold","year":"2005","journal-title":"The Journal of Experimental Medicine"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1007\/s10620-008-0583-5","type":"journal-article","article-title":"Overexpression of mcl-1 attenuates liver injury and fibrosis in the bile duct-ligated mouse","volume":"54","author":"Kahraman","year":"2009","journal-title":"Digestive Diseases and Sciences"},{"key":"bib30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0022-3565(24)29298-3","type":"journal-article","article-title":"Preclinical studies to predict the disposition of Apo2L\/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety","volume":"299","author":"Kelley","year":"2001","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1096\/fj.08-124669","type":"journal-article","article-title":"The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking","volume":"23","author":"Kimberley","year":"2009","journal-title":"FASEB Journal"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/ni894","type":"journal-article","article-title":"Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-\/- mice","volume":"4","author":"Lamhamedi-Cherradi","year":"2003","journal-title":"Nature Immunology"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1182\/blood-2013-04-460162","type":"journal-article","article-title":"Treatment of cancer-associated thrombosis","volume":"122","author":"Lee","year":"2013","journal-title":"Blood"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/cdd.2014.81","type":"journal-article","article-title":"Getting TRAIL back on track for cancer therapy","volume":"21","author":"Lemke","year":"2014","journal-title":"Cell Death and Differentiation"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"24160","DOI":"10.1074\/jbc.M116.751974","type":"journal-article","article-title":"Heparan sulfate regulates the structure and function of osteoprotegerin in osteoclastogenesis","volume":"291","author":"Li","year":"2016","journal-title":"The Journal of Biological Chemistry"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/cdd.2011.123","type":"journal-article","article-title":"Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells","volume":"19","author":"Mazurek","year":"2012","journal-title":"Cell Death and Differentiation"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1200\/JCO.2012.44.1055","type":"journal-article","article-title":"Phase I trial and pharmacokinetic study of lexatumumab in pediatric patients with solid tumors","volume":"30","author":"Merchant","year":"2012","journal-title":"Journal of Clinical Oncology"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1182\/blood.v98.3.795","type":"journal-article","article-title":"TRAIL\/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications","volume":"98","author":"Mitsiades","year":"2001","journal-title":"Blood"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41418-022-01059-z","type":"journal-article","article-title":"Harnessing TRAIL-induced cell death for cancer therapy: a long walk with thrilling discoveries","volume":"30","author":"Montinaro","year":"2023","journal-title":"Cell Death and Differentiation"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","type":"journal-article","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods in Enzymology"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1126\/science.276.5309.111","type":"journal-article","article-title":"The receptor for the cytotoxic ligand TRAIL","volume":"276","author":"Pan","year":"1997","journal-title":"Science"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00280-015-2712-0","type":"journal-article","article-title":"Unexpected hepatotoxicity in a phase I study of TAS266, a novel tetravalent agonistic Nanobody targeting the DR5 receptor","volume":"75","author":"Papadopoulos","year":"2015","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1600-0854.2007.00540.x","type":"journal-article","article-title":"Internalization and trafficking of cell surface proteoglycans and proteoglycan-binding ligands","volume":"8","author":"Payne","year":"2007","journal-title":"Traffic"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/JTO.0b013e31827ce554","type":"journal-article","article-title":"A randomized phase 2 study of paclitaxel and carboplatin with or without conatumumab for first-line treatment of advanced non-small-cell lung cancer","volume":"8","author":"Paz-Ares","year":"2013","journal-title":"Journal of Thoracic Oncology"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"6S17","DOI":"10.1016\/S2542-4513(20)30515-0","type":"journal-article","article-title":"Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for the treatment of cancer-associated thrombosis (which agent for which patient)","volume":"45","author":"Pernod","year":"2020","journal-title":"Journal de Medecine Vasculaire"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1017\/S0033583507004635","type":"journal-article","article-title":"X-ray solution scattering (SAXS) combined with crystallography and computation: defining accurate macromolecular structures, conformations and assemblies in solution","volume":"40","author":"Putnam","year":"2007","journal-title":"Quarterly Reviews of Biophysics"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10585-007-9125-3","type":"journal-article","article-title":"Syndecan-1: a dynamic regulator of the myeloma microenvironment","volume":"25","author":"Sanderson","year":"2008","journal-title":"Clinical & Experimental Metastasis"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.277.5327.818","type":"journal-article","article-title":"Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors","volume":"277","author":"Sheridan","year":"1997","journal-title":"Science"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1084\/jem.193.6.661","type":"journal-article","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis","volume":"193","author":"Smyth","year":"2001","journal-title":"The Journal of Experimental Medicine"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"4442","DOI":"10.1200\/JCO.2011.37.2623","type":"journal-article","article-title":"Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer","volume":"29","author":"Soria","year":"2011","journal-title":"Journal of Clinical Oncology"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1016\/S0006-3495(01)76260-1","type":"journal-article","article-title":"Determination of domain structure of proteins from X-ray solution scattering","volume":"80","author":"Svergun","year":"2001","journal-title":"Biophysical Journal"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1084\/jem.20011171","type":"journal-article","article-title":"Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development","volume":"195","author":"Takeda","year":"2002","journal-title":"The Journal of Experimental Medicine"},{"key":"bib53","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aao4910","type":"journal-article","article-title":"Structural principles of tumor necrosis factor superfamily signaling","volume":"11","author":"Vanamee","year":"2018","journal-title":"Science Signaling"},{"key":"bib54","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nrc.2017.28","type":"journal-article","article-title":"Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy","volume":"17","author":"von Karstedt","year":"2017","journal-title":"Nature Reviews. Cancer"},{"key":"bib55","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cllc.2013.12.005","type":"journal-article","article-title":"Phase II trial of mapatumumab, a fully human agonist monoclonal antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1), in combination with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer","volume":"15","author":"von Pawel","year":"2014","journal-title":"Clinical Lung Cancer"},{"key":"bib56","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03567-1","type":"journal-article","article-title":"Splicing reprogramming of TRAIL\/DISC-components sensitizes lung cancer cells to TRAIL-mediated apoptosis","volume":"12","author":"Voss","year":"2021","journal-title":"Cell Death & Disease"},{"key":"bib57","doi-asserted-by":"publisher","first-page":"5386","DOI":"10.1093\/emboj\/16.17.5386","type":"journal-article","article-title":"TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL","volume":"16","author":"Walczak","year":"1997","journal-title":"The EMBO Journal"},{"key":"bib58","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/5517","type":"journal-article","article-title":"Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo","volume":"5","author":"Walczak","year":"1999","journal-title":"Nature Medicine"},{"key":"bib59","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","type":"journal-article","article-title":"Identification and characterization of a new member of the TNF family that induces apoptosis","volume":"3","author":"Wiley","year":"1995","journal-title":"Immunity"},{"key":"bib60","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev-biochem-060713-035314","type":"journal-article","article-title":"Demystifying heparan sulfate-protein interactions","volume":"83","author":"Xu","year":"2014","journal-title":"Annual Review of Biochemistry"},{"key":"bib61","doi-asserted-by":"publisher","first-page":"917","DOI":"10.4161\/cbt.8.10.8141","type":"journal-article","article-title":"TRAIL induces endocytosis of its death receptors in MDA-MB-231 breast cancer cells","volume":"8","author":"Zhang","year":"2009","journal-title":"Cancer Biology & Therapy"},{"key":"bib62","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-021-01737-7","type":"journal-article","article-title":"pH-dependent and dynamic interactions of cystatin C with heparan sulfate","volume":"4","author":"Zhang","year":"2021","journal-title":"Communications Biology"},{"key":"bib63","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gnh110","type":"journal-article","article-title":"An efficient one-step site-directed and site-saturation mutagenesis protocol","volume":"32","author":"Zheng","year":"2004","journal-title":"Nucleic Acids Research"},{"key":"bib64","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/978-1-60327-058-8_28","type":"journal-article","article-title":"Automated structure solution with the PHENIX suite","volume":"426","author":"Zwart","year":"2008","journal-title":"Methods in Molecular Biology"}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/90192\/elife-90192-v1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/90192\/elife-90192-v1.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/90192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:41:41Z","timestamp":1787568101000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/90192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,24]]},"references-count":64,"alternative-id":["10.7554\/eLife.90192"],"URL":"https:\/\/doi.org\/10.7554\/elife.90192","archive":["CLOCKSS"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.07.26.550758","asserted-by":"subject"},{"id-type":"doi","id":"10.1101\/2023.07.26.550758","asserted-by":"object"}],"is-same-as":[{"id-type":"doi","id":"10.7554\/eLife.90192.3","asserted-by":"subject"}],"is-version-of":[{"id-type":"doi","id":"10.7554\/eLife.90192.1","asserted-by":"subject"},{"id-type":"doi","id":"10.7554\/eLife.90192.2","asserted-by":"subject"}]},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,24]]},"assertion":[{"value":"single anonymised","name":"peer_review_transparency","label":"Peer review transparency","group":{"name":"peer_review_taxonomy"}},{"value":"other reviewer(s), editor","name":"peer_review_interaction","label":"Peer review interaction","group":{"name":"peer_review_taxonomy"}},{"value":"review summaries, review reports, author\/editor communication, reviewer identities reviewer opt in, editor identities","name":"peer_review_published","label":"Peer review published","group":{"name":"peer_review_taxonomy"}},{"value":"open (sign in with ORCID iD required)","name":"post_publication_commenting","label":"Post publication commenting","group":{"name":"post_publication_commenting"}}],"article-number":"RP90192"}}